These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12399193)

  • 1. Effect of monophosphoryl lipid A (MPL) on T-helper cells when administered as an adjuvant with pneumocococcal-CRM197 conjugate vaccine in healthy toddlers.
    Vernacchio L; Bernstein H; Pelton S; Allen C; MacDonald K; Dunn J; Duncan DD; Tsao G; LaPosta V; Eldridge J; Laussucq S; Ambrosino DM; Molrine DC
    Vaccine; 2002 Nov; 20(31-32):3658-67. PubMed ID: 12399193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pentavalent conjugated pneumococcal vaccine in toddlers.
    Pichichero ME; Shelly MA; Treanor JJ
    Pediatr Infect Dis J; 1997 Jan; 16(1):72-4. PubMed ID: 9002106
    [No Abstract]   [Full Text] [Related]  

  • 4. Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.
    Juergens C; Trammel J; Shoji Y; Patterson S; Watson W; Webber C; Gruber WC; Scott DA; Schmoele-Thoma B
    Hum Vaccin Immunother; 2018; 14(8):1948-1956. PubMed ID: 29543583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Immunogenicity and Protective Efficacy of a
    Ramakrishnan A; Schumack NM; Gariepy CL; Eggleston H; Nunez G; Espinoza N; Nieto M; Castillo R; Rojas J; McCoy AJ; Beck Z; Matyas GR; Alving CR; Guerry P; Poly F; Laird RM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043512
    [No Abstract]   [Full Text] [Related]  

  • 6. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine.
    Ko EJ; Lee YT; Kim KH; Lee Y; Jung YJ; Kim MC; Lee YN; Kang T; Kang SM
    J Immunol; 2017 Jan; 198(1):279-291. PubMed ID: 27881702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
    Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM
    Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
    Yang QB; Martin M; Michalek SM; Katz J
    Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers.
    Wuorimaa T; Dagan R; Eskola J; Janco J; Ahman H; Leroy O; Käyhty H
    Pediatr Infect Dis J; 2001 Mar; 20(3):272-7. PubMed ID: 11303829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A.
    Baker PJ; Hiernaux JR; Fauntleroy MB; Prescott B; Cantrell JL; Rudbach JA
    Infect Immun; 1988 May; 56(5):1076-83. PubMed ID: 2965680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody- and cell-mediated immune responses to a synthetic oligosaccharide conjugate vaccine after booster immunization.
    Safari D; Dekker HA; de Jong B; Rijkers GT; Kamerling JP; Snippe H
    Vaccine; 2011 Sep; 29(38):6498-504. PubMed ID: 21767596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults.
    Vandepapelière P; Rehermann B; Koutsoukos M; Moris P; Garçon N; Wettendorff M; Leroux-Roels G
    Vaccine; 2005 Apr; 23(20):2591-601. PubMed ID: 15780441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination.
    Leroux-Roels G; Van Belle P; Vandepapeliere P; Horsmans Y; Janssens M; Carletti I; Garçon N; Wettendorff M; Van Mechelen M
    Vaccine; 2015 Feb; 33(8):1084-91. PubMed ID: 25444781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine adjuvants CpG (oligodeoxynucleotides ODNs), MPL (3-O-deacylated monophosphoryl lipid A) and naloxone-enhanced Th1 immune response to the Plasmodium vivax recombinant thrombospondin-related adhesive protein (TRAP) in mice.
    Nazeri S; Zakeri S; Mehrizi AA; Djadid ND; Snounou G; Andolina C; Nosten F
    Med Microbiol Immunol; 2018 Nov; 207(5-6):271-286. PubMed ID: 29948091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
    Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
    JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates.
    Safari D; Dekker HA; Rijkers G; Snippe H
    Vaccine; 2011 Jan; 29(4):849-54. PubMed ID: 21111776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
    Sen G; Chen Q; Snapper CM
    Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
    Togashi T; Mitsuya N; Kogawara O; Sumino S; Takanami Y; Sugizaki K
    Vaccine; 2016 Aug; 34(38):4635-4641. PubMed ID: 27265451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Haemophilus influenzae type b-CRM(197) conjugate vaccine elicits a mixed Th1 and Th2 CD(4+) T cell cytokine response that correlates with the isotype of antipolysaccharide antibody.
    Kamboj KK; King CL; Greenspan NS; Kirchner HL; Schreiber JR
    J Infect Dis; 2001 Oct; 184(7):931-5. PubMed ID: 11528593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Mazloomi E; Jazani NH; Shahabi S
    Vaccine; 2012 Mar; 30(16):2640-6. PubMed ID: 22342704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.